{"id":"W2175470508","doi":"10.1016/s1474-4422(15)00322-1","title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"National Center for Research Resources; EMD Serono; National Institutes of Health; Acorda Therapeutics; Genentech; Multiple Sclerosis Society; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Sun Pharma; Skirball Foundation; Biogen; Questcor Pharmaceuticals; Sanofi","keywords":"Medicine; Placebo; Estriol; Glatiramer acetate; Internal medicine; Multiple sclerosis; Clinical endpoint; Expanded Disability Status Scale; Randomized controlled trial; Hormone; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00235623,0.0003753107,0.00177684,0.0001168197,0.0002752366,0.00005460477,0.0003221823,0.0001178363,0.00001871569],"category_scores_gemma":[0.004462196,0.0001910723,0.0001211956,0.0002586329,0.0005353543,0.00009221347,0.0001140926,0.000669799,0.00001590079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006946544,"about_ca_system_score_gemma":0.0002613424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003338411,"about_ca_topic_score_gemma":0.00006378925,"domain_scores_codex":[0.9966803,0.000633472,0.0005140714,0.0005494494,0.0005131767,0.001109588],"domain_scores_gemma":[0.9949418,0.003340617,0.0003501984,0.0007119547,0.0003295598,0.0003258576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9870662,0.0003837983,0.001584171,0.00005022976,0.000697209,0.00002590195,0.001417178,0.0002548026,0.001939687,0.00001362876,0.003276834,0.003290378],"study_design_scores_gemma":[0.9611472,0.02465087,0.0007631747,0.00007762459,0.0002418403,0.00004659789,0.000297389,0.008133064,0.0002020173,0.00005589913,0.004174463,0.0002098883],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757608,0.0001710232,0.0006413741,0.01223078,0.0002255292,0.00993006,0.00002747752,0.0001757319,0.0008371948],"genre_scores_gemma":[0.9900199,0.0001015729,0.001050624,0.002236887,0.0009346101,0.005118985,0.00001675268,0.00007852768,0.0004422003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02591901,"threshold_uncertainty_score":0.77917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1127301283862785,"score_gpt":0.3285492548460533,"score_spread":0.2158191264597748,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}